Response to "Permanent makeup: A review of its technique, regulation and complications" [0.03%]
对《文身：技术、监管及并发症回顾》一文的回应
Michelle Sikora,Caitlin Kearney,Mario Lacouture et al.
Michelle Sikora et al.
Kevin Kamel,Karol Roman,Emily Deehan et al.
Kevin Kamel et al.
Response to: Demographic Differences and the Impact of Research Years for Reapplicants to Dermatology Residency Programs: A Retrospective Cohort Study [0.03%]
对皮肤病学住院医师项目重新申请者的回顾性队列研究的回复：人口统计学差异和研究年份的影响
Alexis B Lyons,Henry W Lim,David M Ozog et al.
Alexis B Lyons et al.
Association of Hereditary erythropoietic protoporphyria with SCC: a retrospective case-control study using the TriNetX dataset [0.03%]
遗传性红细胞生成性原卟啉病与鳞状细胞癌的关联：一项基于TriNetX数据库的病例对照研究
Ruhi Kanwar,Thomas Z Rohan,Vinod E Nambudiri
Ruhi Kanwar
Baricitinib and Oral Minoxidil for the Treatment of Alopecia Areata in Pediatric Patients [0.03%]
儿童斑秃患者的巴瑞克替尼和口服ミノキシジル治疗
Kailyn Valido,Brittany G Craiglow
Kailyn Valido
Comments on "Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: a real-world cohort analysis" [0.03%]
“杜普利尤单抗在儿科特应性皮炎中的神经精神结局：真实世界队列分析”的评论
Rong Li,Junyan Zhang,Lei Wang et al.
Rong Li et al.
Response to Li et al.'s "Comments on 'Dupilumab and neuropsychiatric outcomes in pediatric atopic dermatitis: A real-world cohort analysis" [0.03%]
致李等人的评论“关于dupilumab和儿童特应性皮炎神经精神转归的现实队列分析”的回复
Maria Kaltchenko,Elle Kim,Sarah Radtke et al.
Maria Kaltchenko et al.
Optimizing Melanoma Biopsy Practices: Implications for Clinical Accuracy and Patient Outcomes [0.03%]
优化黑色素瘤活检实践：对临床准确性和患者结果的影响
Xichen Fan,Yuxiang Zhao,Xin Zhao
Xichen Fan